Master10
Human Body & Medicine Module

Vaccines, Immunology & Public Health

The human immune system defends against pathogens through innate non-specific barriers (skin, phagocytes) and adaptive immunity mediated by B-lymphocytes (humoral antibody production) and T-lymphocytes (cell-mediated immunity). Edward Jenner developed the first successful vaccine in 1796 using cowpox virus to confer immunity against deadly smallpox. Modern immunization utilizes multiple platforms: inactivated vaccines (Covaxin, Salk polio), live-attenuated vaccines (BCG, MMR, Sabin oral polio), subunit vaccines (Hepatitis B), and mRNA vaccines (Pfizer-BioNTech, Moderna) encoding viral spike proteins. India's Universal Immunization Programme (UIP) and Mission Indradhanush ensure nationwide coverage against vaccine-preventable childhood diseases like diphtheria, pertussis, tetanus, polio, and measles.

Key Concepts & Examination Highlights

  • Edward Jenner pioneered vaccination in 1796 by using cowpox material to induce active immunity against smallpox.
  • Live-attenuated vaccines use a weakened form of the living germ, exemplified by the Bacillus Calmette-Guérin (BCG) vaccine for tuberculosis.
  • The Government of India launched Mission Indradhanush in December 2014 to expand full immunization coverage for children and pregnant women.
  • Innate immunity provides immediate non-specific host defense mechanisms including anatomical skin barriers, lysozyme in tears/saliva, gastric acid, and phagocytes (macrophages and neutrophils).
  • Adaptive immunity is mediated by B-lymphocytes, which produce specific antibodies (immunoglobulins: IgG, IgM, IgA, IgE, IgD), and T-lymphocytes, which direct cell-mediated destruction of infected cells.
  • Inactivated or killed vaccines contain pathogens grown in culture and killed using heat or chemicals (such as formalin), exemplified by the Salk inactivated polio vaccine (IPV) and Covaxin.
  • The oral polio vaccine (OPV), developed by Albert Sabin in 1961, is a live-attenuated vaccine administered orally to stimulate gut mucosal immunity (IgA).
  • Messenger RNA (mRNA) vaccines, such as those developed by Pfizer-BioNTech and Moderna against SARS-CoV-2, deliver lipid nanoparticle-encapsulated mRNA instructing host ribosomes to synthesize viral antigens.
  • Toxoid vaccines utilize inactivated bacterial exotoxins to induce immune memory without causing disease, such as the tetanus toxoid (TT) and diphtheria toxoid components of the DPT vaccine.
  • Herd immunity occurs when a sufficient percentage of a population becomes immune to an infectious pathogen through vaccination or prior infection, indirectly protecting non-immune individuals.
  • Colostrum, the first milk produced after parturition, contains high concentrations of secretory Immunoglobulin A (IgA), providing passive natural immunity to the newborn.
  • Subunit and recombinant protein vaccines, such as the Hepatitis B surface antigen (HBsAg) vaccine and Novavax, use specific purified fragments of the pathogen to stimulate a targeted immune response.
  • Viral vector vaccines, such as Covishield (Oxford-AstraZeneca) and Sputnik V, use modified non-replicating adenoviruses to deliver genetic code encoding the target pathogen antigen into host cells.
  • DNA vaccines deliver engineered plasmids directly into human cells to express viral antigens, exemplified by ZyCoV-D, the world's first approved plasmid DNA vaccine developed by Zydus Cadila in India.
  • Immunoglobulin G (IgG) is the most abundant antibody in human serum (approximately 75-80%) and the only immunoglobulin class capable of crossing the placenta to confer passive immunity to the fetus.
  • Immunoglobulin M (IgM) is the first antibody produced during the primary immune response to an initial pathogen exposure, possessing a pentameric structure with ten antigen-binding sites.
  • Immunoglobulin E (IgE) binds to high-affinity receptors on mast cells and basophils, mediating allergic hypersensitivity reactions and host defense against parasitic helminths.
  • Active immunity is acquired when the host immune system generates its own antibodies and memory lymphocytes following natural infection or vaccination, conferring long-lasting protection.
  • Passive immunity provides immediate, short-term protection through the administration of pre-formed antibodies, such as anti-rabies immunoglobulin or anti-venom serum.
  • Major Histocompatibility Complex (MHC) molecules, known as Human Leukocyte Antigens (HLA) in humans, present peptide fragments to T-cell receptors, where MHC Class I presents to CD8+ cytotoxic T-cells and MHC Class II presents to CD4+ helper T-cells.
  • The complement system is a biochemical cascade of over 30 serum proteins that opsonizes pathogens, recruits inflammatory cells, and forms the Membrane Attack Complex (MAC) to lyse target microbes.
  • Anaphylaxis is a severe, life-threatening systemic Type I hypersensitivity reaction triggered by massive mast cell degranulation, treated immediately with intramuscular epinephrine.
  • Adjuvants, such as aluminum salts (alum), are chemical compounds added to vaccines to enhance the magnitude and duration of the host immune response to the antigen.
  • The cold chain system is a temperature-controlled supply chain that maintains vaccines within the recommended temperature range of 2°C to 8°C from manufacturer to the point of clinical administration.
  • India was officially certified polio-free by the World Health Organization on March 27, 2014, after reporting zero indigenous cases of wild poliovirus transmission for three consecutive years.
  • The central lymphoid organs where lymphocytes originate and mature are the bone marrow (B-cells) and thymus (T-cells), while secondary lymphoid organs (spleen, lymph nodes, MALT) initiate adaptive responses.
  • Natural Killer (NK) cells are innate cytotoxic lymphocytes that recognize and destroy virus-infected cells and tumor cells without prior antigen sensitization, using perforin and granzymes.
  • Pattern Recognition Receptors (PRRs), such as membrane-bound Toll-Like Receptors (TLRs), detect pathogen-associated molecular patterns (PAMPs like LPS and viral dsRNA) to initiate innate immune signaling.
  • Cytokines are low-molecular-weight regulatory signaling proteins (including interleukins, interferons, and tumor necrosis factors) that mediate communication between immune cells.
  • Interferons (IFN-alpha, IFN-beta) are signaling glycoproteins produced by virus-infected host cells that induce an antiviral state in neighboring uninfected cells by halting viral protein translation.
  • Antibody affinity maturation occurs in the germinal centers of secondary lymphoid organs through somatic hypermutation and positive selection of high-affinity B-cell receptors.
  • Class switch recombination allows activated B-cells to switch their antibody constant region from IgM/IgD to IgG, IgA, or IgE without changing antigen specificity.
  • The DPT vaccine is a combination trivalent vaccine providing active immunization against Diphtheria, Pertussis (whooping cough), and Tetanus.
  • The MMR vaccine provides combined live-attenuated viral immunization against Measles, Mumps, and Rubella (German measles).
  • The Rotavirus vaccine (such as indigenous Rotavac developed by Bharat Biotech) is administered orally to infants to protect against severe dehydration and diarrhea caused by rotavirus.
  • Pneumococcal Conjugate Vaccines (PCV13 and PCV15) contain capsular polysaccharides from Streptococcus pneumoniae conjugated to a carrier protein to elicit T-dependent memory in infants.
  • Human Papillomavirus (HPV) vaccines (such as Gardasil 9 and indigenous Cervavac) protect against oncogenic HPV strains (primarily types 16 and 18) responsible for cervical cancer.
  • The Yellow Fever vaccine (17D strain) is a live-attenuated vaccine that confers lifelong immunity with a single subcutaneous dose, mandatory for travel to endemic equatorial zones.
  • The Cholera vaccine (such as Dukoral and Shanchol) is an oral killed whole-cell vaccine that stimulates mucosal sIgA antibody production in the intestinal lumen.
  • The Typhoid Conjugate Vaccine (TCV, such as Typbar-TCV) conjugates the Vi capsular polysaccharide of Salmonella typhi to tetanus toxoid, providing long-lasting immunity in young infants.
  • Monoclonal antibodies (mAbs) ending with the suffix '-mab' are engineered laboratory-produced antibodies designed to bind specific targets, such as Trastuzumab (anti-HER2 in breast cancer).
  • Checkpoint inhibitors in cancer immunotherapy (such as Pembrolizumab targeting PD-1 and Ipilimumab targeting CTLA-4) release the brakes on T-cells to attack malignant tumors.
  • Immune tolerance is the state of unresponsiveness of the immune system to specific substances, where central and peripheral tolerance mechanisms eliminate self-reactive lymphocytes to prevent autoimmunity.
  • Graft-versus-Host Disease (GVHD) is a serious immunological complication following allogeneic hematopoietic stem cell transplantation where donor immune T-cells attack host tissues.
  • The tuberculin skin test (Mantoux test) assesses cell-mediated (Type IV delayed-type) hypersensitivity to intradermally injected purified protein derivative (PPD) of tuberculin.
  • The Coombs test (antiglobulin test) detects anti-erythrocyte antibodies in hemolytic disease of the fetus and newborn (Rh incompatibility) and autoimmune hemolytic anemias.
  • Rh incompatibility (erythroblastosis fetalis) occurs when an Rh-negative mother carries an Rh-positive fetus, prevented by administering anti-Rh(D) immunoglobulin (RhoGAM) at 28 weeks gestation.
  • The complement fixation test (CFT) is a classic serological diagnostic technique that detects the presence of specific antigens or antibodies by measuring complement consumption.
  • Pulse Polio Immunization Programme was established in India in 1995 to conduct nationwide mass oral polio vaccination campaigns on designated National Immunization Days.
  • The Central Drugs Standard Control Organization (CDSCO), headed by the Drugs Controller General of India (DCGI), is the national regulatory authority responsible for approving vaccines and drugs in India.
Curriculum & Reference Sources: Ministry of Health and Family Welfare (MoHFW), World Health Organization (WHO Immunization Data), CDC Immunology

Sample Solved Questions & Concept Explanations

8 Verified Concept Questions
Q1.EASY

Who developed the world's first successful vaccine in 1796 using cowpox fluid to immunize humans against deadly smallpox?

Q2.EASY

What does the pediatric vaccine acronym "BCG" stand for, widely administered at birth to protect against tuberculosis?

Q3.EASY

What are "Antibodies" (Immunoglobulins - Ig) in the human adaptive immune system?

Q4.EASY

Which type of immunity is acquired when a person receives pre-formed antibodies directly (such as maternal antibodies via breastmilk or antivenom serum)?

Q5.EASY

The "DPT Vaccine" is a triple combination pediatric immunization that protects infants against which three dangerous bacterial diseases?

Q6.EASY

The "MMR Vaccine" is a live attenuated viral vaccine routinely administered in childhood to protect against which three viral illnesses?

Q7.MEDIUM

The "MHC" (Major Histocompatibility Complex, known as HLA in humans) molecules perform which fundamental function in antigen recognition by T cells?

Q8.MEDIUM

What is an "Adjuvant" in vaccine formulation (such as Aluminium hydroxide or MF59)?